#IonOpticks
IonOpticks at #ASMS2025: Our biggest yet.
April 22, 2025 at 2:15 AM
Attending HUPO 2026? Register for the IonOpticks Breakfast Seminar featuring Dr Zilu Ye, Chinese Academy of Medical Sciences, China, Dr Shungo Adachi, National Cancer Center Research Institute, Japan and Dr Liang Chen, IonOpticks, Australia.
Breakfast will be provided
ionopticks.com/our-event/io...
September 23, 2026 at 2:57 AM
We're pleased to welcome Dr Denise Tran to IonOpticks as Applications Scientist, based in Oxford, UK. She'll support researchers with LC-MS proteomics workflows, applications and method development, and help optimise performance, troubleshoot challenges and get the best from IonOpticks columns.
July 20, 2026 at 4:38 AM
IonOpticks is proud to officially open a new purpose-built facility at Milton Park in Oxfordshire UK, expanding its global presence with local order processing, distribution, warehoused stock, commercial and scientific expertise, and a dedicated applications development laboratory.

Read online:
IonOpticks opens UK-based facility to bring faster access, local expertise and application support closer to European researchers
IonOpticks' new facility, based in the Milton Park scientific precinct south of Oxford, brings together order processing and distribution, locally warehoused stock, administrative support, commercial ...
ionopticks.com
July 23, 2026 at 12:52 PM
IonOpticks expands in Europe with two key appointments: Joris Frenz, PhD as BDM and Dr. Britta Diedrich as Senior BDM. Together they bring scientific and commercial expertise to support DACH/European researchers and boost access to IonOpticks’ leading LC-MS solutions. Read more.
IonOpticks strengthens European operations with key business development appointments.
MELBOURNE, AUSTRALIA | Tuesday August 26, 2025 IonOpticks, a world-leading provider of liquid chromatography solutions, today announces two strategic appointments to expand its European operations, st...
www.linkedin.com
August 26, 2025 at 10:53 AM
Big things are happening at IonOpticks! We’re excited to welcome Erik Verschuuren as Head of Global Sales & Zac Anderson as BDM for North America. Their expertise will strengthen our global reach & expand access to world-leading chromatography for researchers everywhere.

Read the full announcement:
IonOpticks announces strategic global expansion with key leadership appointments IonOpticks
IonOpticks, a world-leading provider of chromatography solutions, today announce two key appointments to strengthen its global operations, enhancing access and support for the LC-MS industry. Erik Ver...
ionopticks.com
February 23, 2025 at 11:27 PM
We’re pleased to be in Hamburg for the Third Top-Down Proteomics Symposium. Stop by MS Wil, where Erik is available to discuss your workflows and IonOpticks products. Also on display, is IonOpticks’ top-down poster presentation Stop by and view the data with Erik from 1:00pm - 1:45pm.
August 28, 2025 at 2:16 AM
Yesterday, IonOpticks and SCIEX hosted a hands-on Proteomics in Practice workshop at SCIEX’s Toronto R&D site, giving attendees real-world experience with IonOpticks columns and ZenoTOF systems. Thanks to Tim Heymann, Shelley Jager, Reza Dorvash, Patrick Pribil, Katherine Tran and Jarrod Sandow.
November 14, 2025 at 12:38 PM
IonOpticks is proud to sponsor the 2026 @ubuntuproteomix.bsky.social in George, South Africa. Join IonOpticks' CPO @jsandow.bsky.social, on site all week and catch his sponsor presentation “Chromatography Fundamentals for Proteomic Analysis” Thursday 5 Feb, 10:30am - 12:30pm.
February 1, 2026 at 10:57 PM
We are thrilled to have IonOpticks again as our long-standing sponsor of the Student Proteomics Fund (SPF)! 🙌

Thank you, IonOpticks, for your continued support and for helping make a difference in the world of science! 🔬💡

#YPIC #SPF #Ionopticks
January 13, 2026 at 9:28 AM
Researchers have made a major step in understanding microglial heterogeneity in neurodegenerative diseases. Tuddenham et al. identified 12 distinct microglial subpopulations and mapped their state transitions.

Learn more: bit.ly/41i1USR

#Neuroscience #Proteomics
A cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states - IonOpticks
This living human microglia study by Tuddenham et al. was conducted utilising a 25cm IonOpticks Aurora Ultimate CSI UHPLC column.
bit.ly
December 8, 2024 at 10:31 PM
Following the opening of its new UK facility, IonOpticks is expanding its US presence with local stock in Pennsylvania, faster fulfilment, North America-based applications support and dedicated regional expertise. Read the full release.
IonOpticks announces expanded US presence to bring products and support closer to North American researchers
IonOpticks today announces a further expansion of its global presence, with strengthened operations and customer support across the United States.The expansion improves access to IonOpticks’ advanced ...
ionopticks.com
July 24, 2026 at 3:30 PM
​The future of proteomics in Europe is looking bright! Grateful to @ionopticks.com for supporting early-career researchers (ECRs) at the recent gathering in Madrid. 🚀📊

#Proteomics #Science #Research #Madrid #YPIC #IonOpticks
We're proud to have sponsored the 3rd @ypic.bsky.social Annual Proteomics Gathering, held last week in Madrid. It was a fantastic opportunity for EC researchers to connect with the wider European proteomics community. Joris was delighted to champion the next generation of proteomics researchers.
April 22, 2026 at 5:24 AM
IonOpticks is proud to sponsor the 4th HUPO-HIPP Summer School in Singapore, training the next generation of immunopeptidomics researchers. Zac Anderson and Ying Ying Chan had the opportunity to attend presentations and connect with delegates. Our thanks to the organisers, speakers and attendees.
September 24, 2026 at 1:01 AM
New plasma glycoproteomics method out of the @hecklab.bsky.social uses narrow-window DIA on Orbitrap Astral with Aurora Ultimate XT column. 50% more glycopeptide IDs vs. traditional approaches, with 181 glycoproteins detected across 7 orders of magnitude in just 10-40 minute runs.

bit.ly/45bDXhv
Revolutionising plasma glycoproteomics with Orbitrap Astral and narrow-window DIA - IonOpticks
Jager et al.'s study into plasma glycoproteomics uses a 25 cm x 75 μm IonOpticks Aurora Ultimate 25x75 UHPLC column.
bit.ly
August 17, 2025 at 11:28 PM
The Annual Proteomics Gathering is underway at the Facultad de Farmacia, Universidad Complutense de Madrid, and we’re thrilled to be here!
1/3
#APG #YPIC #EuPA #SEPROT #Ionopticks
April 16, 2026 at 10:32 AM
New study by Forero et al. advances our understanding of EV-mediated cellular crosstalk in neurodevelopment. IonOpticks Aurora Ultimate column enables detailed protein profiling of these complex biological samples.

Read the full study: bit.ly/40OH2St
Extracellular vesicle-mediated trafficking of molecular cues during human brain development - IonOpticks
This human brain development study by Forero et al., was conducted utilising a 25cm IonOpticks Aurora Ultimate UHPLC column.
bit.ly
January 28, 2025 at 3:58 AM
Researchers demonstrate how E2 ubiquitin-conjugating enzymes can be used for targeted protein degradation, offering a new approach to edit the proteome.

The IonOpticks Aurora column enabled researchers to perform high-resolution proteomic analysis.

Learn more: bit.ly/42y4hlc
Targeted protein degradation using chimeric human E2 ubiquitin-conjugating enzymes - IonOpticks
This ubiquitin-conjugating enzymes study by Taylor et al. was conducted using a 25cm IonOpticks Aurora Ultimate UHPLC column.
bit.ly
February 2, 2025 at 10:18 PM
IonOpticks was proud to attend the @ubuntuproteomix.bsky.social Summer School for 2026. Dr @jsandow.bsky.social presented on chromatography fundamentals, we sponsored three students & provided our popular IO hats for all. Thanks to the organisers for another great event & we look forward to 2027.
February 9, 2026 at 3:07 AM
It’s been a great start to the BSPR Annual Meeting 2025 in Liverpool. If you haven’t already, stop by the IonOpticks booth today, where Erik would be delighted to chat about how our new releases can elevate your proteomics workflows.
July 9, 2025 at 4:12 AM
New Slice-PASEF method by @lrsinn.bsky.social et al. boosts proteomics sensitivity by 84% using Aurora Ultimate 25x75 CSI columns + MS incl. timsTOF SCP. Achieves 100% MS/MS duty cycle vs 12.5% conventional. Enables single-cell proteomics at 135 cells/day throughput.

Learn more: bit.ly/4oz7Oaz
Slice-PASEF: Maximising Ion Utilisation in LC-MS Proteomics - IonOpticks
This study into maximising ion utilisation by Sinn et al., was conducted using a 25 cm x 75 um IonOpticks Aurora Ultimate 25x75 UHPLC column.
bit.ly
November 2, 2025 at 10:44 PM
Sinha et al. use spatial proteomics to investigate what makes carotid plaques prone to rupture, potentially causing strokes.

Findings could transform how we assess stroke risk, moving beyond stenosis measurements to molecular profiling, & suggest a therapeutic approach.

Learn more: bit.ly/3R7qIGZ
Spatially resolved proteomic signatures of atherosclerotic carotid artery disease - IonOpticks
This atherosclerotic carotid artery disease study by Sinha et al. was conducted using a 15 cm IonOpticks Aurora Elite 15x75 CSI UHPLC column.
bit.ly
April 27, 2025 at 11:57 PM
PRESS RELEASE: IonOpticks launches Generation 4 Aurora Series® columns - our most advanced yet. With improved robustness, longevity, and sensitivity, Generation 4 sets a new standard for LC-MS performance.
Read the full release:
IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography - IonOpticks
IonOpticks, a leading global producer of high-performance chromatography columns, sets a new benchmark in chromatography with launch of its Generation 4 Aurora Series®
ionopticks.com
May 28, 2025 at 9:19 AM
Recognition is most impactful when it’s consistent and done in a variety of ways. On Friday, we added a whole new way of recognising our people, incorporating IonOpticks' Employee Values Awards into our EOY staff event. Thank you to everyone in the team for making every day at IonOpticks a pleasure.
December 3, 2025 at 4:06 AM
QuantSelect: Mann lab's new deep learning framework improves DIA proteomics quantification by 12-15%. Validated on Orbitrap Astral + Evosep One with Aurora Rapid 5x75 columns. Up to 4× better sensitivity in differential expression analysis.

Learn more: bit.ly/3NyqqKG

@mpibiochem.bsky.social
Preprint: Deep learning-driven fragment ion selection for improved quantification in MS based proteomics - IonOpticks
This Mann lab study into deep learning-driven fragment ion selection by Vu et al. used IonOpticks Aurora Rapid 5×75 UHPLC columns.
bit.ly
January 22, 2026 at 8:12 AM